$VTRS
2 catalysts touching VTRS in the last 60 days, newest first, each with the price move that followed.
- 95
Viatris to acquire Pacira BioSciences for $36.50/share cash
Viatris Inc. and Pacira BioSciences entered into a definitive merger agreement on October 8, 2026, with Viatris acquiring all outstanding shares at $36.50 per share in cash via tender offer followed by statutory merger. The price and structure are now contractually binding, making completion highly probable pending HSR clearance and shareholder-vote-free statutory mechanics under Delaware law.
- 85
Viatris to acquire Pacira BioSciences for $36.50/share in cash
Viatris announced a definitive merger agreement to acquire all outstanding shares of Pacira BioSciences for $36.50 per share in cash via a tender offer followed by merger. This is a material M&A transaction that will increase Viatrs' debt/capital obligations and dilute shareholder value through a large cash outlay, while Pacira shareholders receive a fixed price offer representing the deal's value realization.
Information only. AURA does not give buy or sell recommendations.